Samy Ammari

8.9k total citations · 2 hit papers
114 papers, 4.6k citations indexed

About

Samy Ammari is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Samy Ammari has authored 114 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Oncology, 48 papers in Radiology, Nuclear Medicine and Imaging and 33 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Samy Ammari's work include Cancer Immunotherapy and Biomarkers (42 papers), Radiomics and Machine Learning in Medical Imaging (34 papers) and Medical Imaging Techniques and Applications (14 papers). Samy Ammari is often cited by papers focused on Cancer Immunotherapy and Biomarkers (42 papers), Radiomics and Machine Learning in Medical Imaging (34 papers) and Medical Imaging Techniques and Applications (14 papers). Samy Ammari collaborates with scholars based in France, United States and Italy. Samy Ammari's co-authors include Laurent Dercle, Aurélien Marabelle, Jean‐Charles Soria, Christophe Massard, Stéphane Champiat, Antoine Hollebecque, Charles Ferté, Éric Deutsch, Sophie Postel‐Vinay and Alexander M.M. Eggermont and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Samy Ammari

107 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hyperprogressive Disease Is a New Pattern of Progression in Cancer Patients Treated by Anti-PD-1/PD-L1

2016 867 citations Stéphane Champiat, Laurent Dercle et al. Clinical Cancer Research profile →
A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: an imaging biomarker, retrospective multicohort study

2018 825 citations Roger Sun, Elaine Johanna Limkin et al. profile →

Peers

Countries citing papers authored by Samy Ammari

Since Specialization

Citations

This map shows the geographic impact of Samy Ammari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samy Ammari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samy Ammari more than expected).

Fields of papers citing papers by Samy Ammari

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samy Ammari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samy Ammari. The network helps show where Samy Ammari may publish in the future.

Co-authorship network of co-authors of Samy Ammari

This figure shows the co-authorship network connecting the top 25 collaborators of Samy Ammari. A scholar is included among the top collaborators of Samy Ammari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samy Ammari. Samy Ammari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The correlation of liquid biopsy genomic data to radiomics in colon, pancreatic, lung and prostatic cancer patients 2025 ·European Journal of Cancer ·Antoine Italiano, (unknown), Jakob Dupont, Tarek Assi, (unknown), (unknown), Alexandre Bône, (unknown), (unknown), Samy Ammari, Arnaud Bayle, Étienne Rouleau, Paul-Henry Cournède, Isabelle Borget, Benjamin Besse, Fabrice Barlési, (unknown), (unknown)	1
2	Body Composition to Define Prognosis of Cancers Treated by Anti-Angiogenic Drugs 2023 ·Diagnostics ·Pierre Decazes, Samy Ammari, (unknown), (unknown), (unknown), (unknown), Baya Benatsou, Laurence Albigès, Corinne Balleyguier, Pierre Véra, Nathalie Lassau	4
3	Intratumoral Immunotherapy: Is It Ready for Prime Time? 2023 ·Current Oncology Reports ·Mario Ghosn, Lambros Tselikas, Stéphane Champiat, Frédèric Deschamps, (unknown), (unknown), (unknown), François‐Xavier Danlos, Siham Farhane, Sandrine Susini, (unknown), Samy Ammari, Aurélien Marabelle, Thierry de Baère	10
4	Synergic prognostic value of 3D CT scan subcutaneous fat and muscle masses for immunotherapy-treated cancer 2023 ·Journal for ImmunoTherapy of Cancer ·Pierre Decazes, Samy Ammari, (unknown), (unknown), (unknown), (unknown), Hugues Talbot, Siham Farhane, Paul-Henry Cournède, Aurélien Marabelle, Florian Guisier, David Planchard, Tony Ibrahim, Caroline Robert, Fabrice Barlési, Pierre Véra, Nathalie Lassau	9
5	Clinical transfer of AGuIX®-based radiation treatments for locally advanced cervical cancer: MR quantification and in vitro insights in the NANOCOL clinical trial framework 2023 ·Nanomedicine Nanotechnology Biology and Medicine ·(unknown), Michele Mondini, Cyrus Chargari, (unknown), (unknown), Samy Ammari, Sophie Bockel, Catherine Genestie, Ting‐Di Wu, François Lux, Olivier Tillement, S. Lacombe, Éric Deutsch, Charlotte Robert, Erika Porcel	9
6	Better than RECIST and Faster than iRECIST: Defining the Immunotherapy Progression Decision Score to Better Manage Progressive Tumors on Immunotherapy 2023 ·Clinical Cancer Research ·(unknown), Hugues Talbot, Nathalie Lassau, (unknown), Siham Farhane, (unknown), (unknown), (unknown), (unknown), Paul-Henry Cournède, (unknown), (unknown), Michèle Kind, Antoîne Italiano, Aurélien Marabelle, Samy Ammari, Stéphane Champiat	2
7	Profile and outcome of cancer patients enrolled in contemporary phase I trials 2023 ·European Journal of Cancer ·(unknown), Anas Gazzah, (unknown), Ratislav Bahleda, Antoine Hollebecque, Jean‐Marie Michot, Capucine Baldini, Samy Ammari, Stéphane Champiat, Aurélien Marabelle, Sophie Postel‐Vinay, Vincent Ribrag, Yohann Loriot, Santiago Ponce Aix, Linda Mahjoubi	2
8	Immunosuppressant mycophenolate mofetil for patients with steroid-refractory immune-related hepatitis induced by checkpoint inhibitors in oncology 2023 ·European Journal of Cancer ·(unknown), Ariane Laparra, (unknown), (unknown), (unknown), François‐Xavier Danlos, (unknown), Antoine Hollebecque, Caroline Even, Samy Ammari, Capucine Baldini, Stéphane Champiat, Benjamin Besse, Caroline Robert, Catherine Guettier, Didier Samuel, Olivier Lambotte, Eléonora De Martin, Jean‐Marie Michot	11
9	Radiological patterns of tumour progression in patients treated with a combination of immune checkpoint blockers and antiangiogenic drugs 2022 ·European Journal of Cancer ·(unknown), Capucine Baldini, (unknown), Tarek Assi, Alice Bernard‐Tessier, P. Martin Romano, Antoine Hollebecque, Loïc Verlingue, Arthur Géraud, Jean‐Marie Michot, Jean‐Pierre Armand, Jean‐Charles Soria, Christophe Massard, Samy Ammari	3
10	Interventional Radiology for Local Immunotherapy in Oncology 2021 ·Clinical Cancer Research ·Lambros Tselikas, Stéphane Champiat, Rahul A. Sheth, (unknown), Samy Ammari, Frédèric Deschamps, Siham Farhane, Charles Roux, Sandrine Susini, Séverine Mouraud, Alexandre Delpla, (unknown), Caroline Robert, Christophe Massard, Fabrice Barlési, Jean‐Charles Soria, Aurélien Marabelle, Thierry de Baère	26
11	Machine-Learning-Based Radiomics MRI Model for Survival Prediction of Recurrent Glioblastomas Treated with Bevacizumab 2021 ·Diagnostics ·Samy Ammari, (unknown), Tarek Assi, Mehdi Touat, Émilie Chouzenoux, (unknown), Elaine Johanna Limkin, Laurent Dercle, (unknown), (unknown), Salma Moalla, Mohamed Khettab, Corinne Balleyguier, Nathalie Lassau, Sarah Dumont, Cristina Smolenschi	14
12	RCP Pacifique : bilan après un an et 323 cancers rares et/ou complexes discutés 2021 ·Bulletin du Cancer ·Charles Honoré, (unknown), Arthur Géraud, Nicolas Epaillard, Gabriel Garcia, Émeline Colomba, Margarida Matias, (unknown), Samy Ammari, Mohamed Khettab, (unknown), Olivier Mir, Michel Ducreux, (unknown)	0
13	Performance of Conventional and Machine-Learning Approaches for the Diagnosis of Tumor Recurrence on MRI after Radiation Therapy of Brain Metastases 2021 ·(unknown), Samy Ammari, Behnam Rabiee, (unknown), (unknown), (unknown), (unknown), Corinne Balleyguier, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), M. Laurence, Elaine Johanna Limkin, S. Bockel, Mohamed Khettab, Charlotte Robert, Alexandre Carré, Sylvain Reuzé, Nathalie Lassau, (unknown), Émilie Chouzenoux, Laurent Dercle	1
14	Methodological Study to Investigate the Potential of Ultrasound-Based Elastography and Texture as Biomarkers to Monitor Liver Tumors 2020 ·Diagnostics ·Salma Moalla, (unknown), Stéphanie Franchi‐Abella, Samy Ammari, Corinne Balleyguier, Nathalie Lassau, Stéphanie Pitre-Champagnat	3
15	Outcome of older cancer patients infected with Covid19 at Gustave Roussy Cancer Center 2020 ·Clinical Cancer Research ·(unknown), Capucine Baldini, Stéphanie Foulon, Arnaud Bayle, Bertrand Gachot, Fanny Pommeret, H. Vincent, (unknown), (unknown), Christophe Willekens, Frank Griscelli, Florence Netzer, Corinne Balleyguier, Samy Ammari, Fabrice André, Florian Scotté, Benjamin Besse, Jean‐Charles Soria, Fabrice Barlési, Laurence Albigès	2
16	Littre’s Hernia: A Unusual Tricky Situation of Meckel’s Diverticulum 2019 ·(unknown), (unknown), Samy Ammari, (unknown)	1
17	Long-Term Survival in Patients Responding to Anti–PD-1/PD-L1 Therapy and Disease Outcome upon Treatment Discontinuation 2018 ·Clinical Cancer Research ·Marie-Léa Gauci, Émilie Lanoy, Stéphane Champiat, Caroline Caramella, Samy Ammari, Sandrine Aspeslagh, Andréa Varga, Capucine Baldini, Rastilav Bahleda, Anas Gazzah, Jean‐Marie Michot, Sophie Postel‐Vinay, Eric Angevin, Vincent Ribrag, Antoine Hollebecque, Jean‐Charles Soria, Caroline Robert, Christophe Massard, Aurélien Marabelle	106
18	PV-0528: An innovative MRI harmonization method allowing large scale radiomics analysis in glioblastoma 2018 ·Radiotherapy and Oncology ·Sylvain Reuzé, (unknown), Roger Sun, Fanny Orlhac, G. Louvel, Samy Ammari, Éric Deutsch, (unknown)	2
19	Hyperprogressive Disease Is a New Pattern of Progression in Cancer Patients Treated by Anti-PD-1/PD-L1 breakdown → 2016 ·Clinical Cancer Research ·Stéphane Champiat, Laurent Dercle, Samy Ammari, Christophe Massard, Antoine Hollebecque, Sophie Postel‐Vinay, Nathalie Chaput, Alexander M.M. Eggermont, Aurélien Marabelle, Jean‐Charles Soria, Charles Ferté	867
20	Tumor Growth Rate Is an Early Indicator of Antitumor Drug Activity in Phase I Clinical Trials 2013 ·Clinical Cancer Research ·Charles Ferté, (unknown), Antoine Hollebecque, Serge Koscielny, Antonin Lévy, Christophe Massard, (unknown), Brian M. Bot, Carlos Gomez‐Roca, Clarisse Dromain, Samy Ammari, Jean‐Charles Soria	130

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact